Narus Financial Partners, LLC Bristol Myers Squibb CO Transaction History

Narus Financial Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$57.89 - $64.73 $6,773 - $7,573	-117 Reduced 2.58%	4,418 $256 Million
Q2 2023 Aug 30, 2023	SELL	$63.71 - $70.74 $1,465 - $1,627	-23 Reduced 0.5%	4,535 $290 Million
Q1 2023 Jun 27, 2023	BUY	$65.71 - $74.53 $299,506 - $339,707	4,558 New	4,558 $316 Million
Q3 2022 Oct 12, 2023	SELL	$0.13 - $76.84 $10 - $6,070	-79 Reduced 1.74%	4,456 $317 Million
Q2 2022 Oct 12, 2023	SELL	$72.62 - $79.98 $2,105 - $2,319	-29 Reduced 0.64%	4,506 $347 Million
Q1 2022 Sep 12, 2023	SELL	$61.48 - $73.72 $75,313 - $90,307	-1,225 Reduced 27.01%	3,310 $242 Million
Q1 2021 Mar 07, 2024	BUY	$59.34 - $66.74 $203,595 - $228,984	3,431 New	3,431 $217 Million
Q4 2019 May 14, 2024	BUY	$49.21 - $64.19 $163,229 - $212,918	3,317 New	3,317 $213 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Narus Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Narus Financial Partners, LLC with notifications on news.